An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...
New Scientist on MSN
Bone cancer therapy unexpectedly makes tumours less painful
A drug that kills cancer cells by puncturing them comes with an additional benefit: tests in mice suggest it reduces the ...
More than three decades ago, the U.S. Food and Drug Administration (FDA) approved Bacillus Calmette-Guérin (BCG) as the first immunotherapy against cancer. And it is still used today to treat ...
Researchers have been able to identify at least three distinct subtypes of a rare type of bone cancer for the first time, which could transform clinical trials and patient care. Researchers have been ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results